Welcome to evaluation and analysis of medication in Chinese hospitals
ISSN 1672-2124 CN11-4975/R
|
English
简体中文
English
Evaluation and analysis of medicinal in Chinese hospitals
Supervisory unit:
China Medical Biotechnology Association
Organizer:
China Medical Biotechnology Association & Chongqing University Cancer Hospital
Home
Articles online
Journal inclusion
Editorial board
Contact us
Cost-Effectiveness Analysis of Tislelizumab Combined with Chemotherapy for the First-Line Treatment of Extensive-Stage Small Cell Lung Cancer in China
Author:GAO Yuan、 WANG Liangxiao、YAN Chunyan、 DIAO Ruigang、 LÜ Na
6 pages
12
8
Download PDF
Previous
Next